l carnitine tmao conversion Linking anaerobic gut bacteria and cardiovascular disease Dietary Fatty Acids Modulate Gut

Shared epigenetic resistance mechanisms/targets of sorafenib and lenvatinib The epigenetic mechanisms underlying sorafenib/lenvatinib resistance encompass shared regulatory processes, including DNA/RNA methylation, histone modifications, and non-coding RNA regulation, and shared resistance outcomes involving dysregulated programmed cell death, metabolic reprogramming, enhanced cancer stem cell properties, and uncontrolled proliferative signaling pathways

for example, losartan and nilvadipine both have anti-inflammatory qualities that can lessen the neuroinflammation linked to AD

PMID 24056189

Of the 66 patients treated prophylactically, 25 (38%) experienced no bleeding episodes, 44 (67%) experienced no spontaneous bleeding episodes, and 48 (73%) experienced no joint bleeding episodes